Bolus Administration of Landiolol, a Short-Acting, Selective β1-Blocker, to Treat Tachycardia During Anesthesia: A Dose-Dependent Study

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 6, 2006, Pages 793-795

  Harasawa, Rei ^a   Hayashi, Yukio ^a   Iwasaki, Mitsuo ^a   Kamibayashi, Takahiko ^a   Mashimo, Takashi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

anesthesia; landiolol; tachycardia

Indexed keywords

ANESTHETIC AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; LANDIOLOL; SHORT ACTING DRUG;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DRUG DOSE REGIMEN; DRUG INJECTION VOLUME; FACE TUMOR; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; INTRACRANIAL TUMOR; MALE; MAXILLA TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THERAPY EFFECT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; ANESTHESIA, GENERAL; BLOOD PRESSURE; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHOLINES; PROSPECTIVE STUDIES; TACHYCARDIA; TIME FACTORS; TREATMENT OUTCOME; UREA;

EID: 33751309153     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.11.009     Document Type: Article

References (10)

1. Kanitz D.D., Ebert T.J., and Kampine J.P. Intraoperative use of bolus doses of esmolol to treat tachycardia. J Clin Anesth 2 (1990) 238-242
2. Miller D.R., Martineau R.J., Wynands J.E., et al. Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: The Canadian multicentre trial. Can J Anaesth 38 (1991) 849-858
3. Iguchi S., Iwamura H., Nishizaki M., et al. Development of a highly cardioselective ultra-short-acting β-blocker, ONO-1101. Chem Pharm Bull 40 (1992) 1462-1469
4. Atarashi H., Kumura A., Yashima M., et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting β-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 68 (2000) 143-150
5. Hoffman B.B. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. (ed 10) (2001), McGraw-Hill, New York, NY 215-268
6. Sugiyama A., Takahara A., and Hashimoto K. Electrophysiologic, cardiohemodynamic and β-blocking actions of a new ultra-short-acting β-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 34 (1999) 70-77
7. Sasano J., Tarver S.D., Kindscher J.D., et al. In rabbits, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 48 (2001) 985-989
8. Kitamura A., Sakamoto A., Inoue T., et al. Efficacy of an ultrashort-acting β-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur J Clin Pharmacol 51 (1997) 467-471
9. Hirota K., Baba S., Fukuchi S., et al. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy. J Anesth 19 (2005) 17-20
10. Reves J.G., and Flezzani P. Perioperative use of esmolol. Am J Cardiol 56 (1985) 57F-62F